PMOS Treatment Options: What You Need to Know Before Considering Surgery

Surgery for Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as Polycystic Ovary Syndrome (PCOS), is not a first-line treatment.

For the vast majority of patients, PMOS-related infertility is managed successfully through lifestyle modifications and optimized medical ovulation induction.

Surgery is strictly reserved for “resistant cases,” defined as individuals who fail to ovulate or conceive even after a specialist has fully optimized the dosage, timing, and protocol of fertility medications.

PMOS is more than a hormonal imbalance. For many women, it is a life-changing diagnosis that affects not just their menstrual cycles but their ability to conceive naturally over time.

Living with PMOS for months and years often means navigating unpredictable ovulation, irregular cycles, and the emotional weight of unexplained infertility.

The condition does not have a permanent cure, but this does not mean outcomes are poor. With the right clinical management, one that is tailored to the individual rather than applied as a blanket protocol, the majority of women with PMOS can restore ovulatory function and achieve natural conception.

The key lies in approaching treatment in the correct sequence, with the right level of clinical expertise at each step.

If you have been recently diagnosed with PMOS or have been struggling to conceive despite ongoing treatment, a specialist evaluation to review your current protocol is a well-considered next step.

No. Surgery is never the first-line treatment for Polyendocrine Metabolic Ovarian Syndrome (PMOS).

It should only be considered when medically indicated and after all appropriate non-surgical treatment options have been carefully evaluated and exhausted.

The standard first-line approach for women with PMOS who are trying to conceive is ovulation induction, the use of medications to stimulate the ovaries to release an egg.

Commonly used agents include letrozole, human menopausal gonadotropins (hMG), and recombinant FSH. These medications are effective for a significant proportion of women when prescribed and monitored correctly.

The more important question before considering surgery is often not whether the medications have failed, but whether they were used optimally.

In clinical practice, many cases of apparent drug resistance are actually cases of suboptimal protocol design.

Key questions that need to be answered before escalating to surgery include:

• Was an extended letrozole protocol considered and tried?
• Were the dose and timing of stimulation appropriately adjusted based on ultrasound monitoring and hormone levels?
• Was the stimulation protocol individualised based on past cycle performance?

In many women referred for surgical evaluation, revisiting and optimising the stimulation protocol rather than proceeding to surgery produces the desired ovulatory response.

A revised, customised stimulation plan based on detailed ultrasound findings, hormonal profiling, and prior cycle data is often sufficient to avoid surgery entirely.

Surgery for PMOS is appropriate only when there is a genuine absence of response even after the stimulation protocol has been properly reviewed, adjusted, and optimised.

When comprehensive medical protocols fail to stimulate ovulation, surgical intervention may be discussed. Modern reproductive medicine recognizes two primary techniques, both classified as ovarian drilling.

When a patient with PMOS has not responded to optimised medical therapy, two surgical options exist. Both involve a technique called ovarian drilling, a procedure that uses controlled energy delivery to the ovaries to reduce androgen-producing tissue and restore hormonal balance.

The two approaches are Laparoscopic Ovarian Drilling (LOD) and Transvaginal Ovarian Drilling (TVOD).

What Is Transvaginal Ovarian Drilling (TVOD) and Who Is It For?

Transvaginal Ovarian Drilling is an experimental procedure with very limited indications. It is not a routine treatment for PMOS and should not be recommended or offered to patients as a general option.

TVOD may be considered only in a highly selective group of patients, specifically those who present with extremely severe PMOS requiring immediate stimulation, those who have demonstrated poor egg quality or low AMH levels, women who have experienced poor embryo quality in previous IVF cycles, and those who have shown poor ovarian response despite adequate stimulation.

Because this procedure is experimental, it must only be performed in highly specialised centres with the appropriate expertise and infrastructure. It is not appropriate for general PMOS management, and patients should be cautious of any provider recommending it as a standard option.

What Is Laparoscopic Ovarian Drilling (LOD) and Is It Still Relevant?

Laparoscopic Ovarian Drilling (LOD) is a well-established, evidence-based surgical technique that has been used for decades in the management of resistant PMOS.

Despite criticism in some online communities and patient support groups, many of these concerns are based on outdated surgical techniques rather than modern approaches.

When performed correctly using contemporary methods, LOD remains a safe, effective, and fertility-preserving surgical option for carefully selected women with severe or resistant PMOS, including lean PMOS patients who have not responded to medications or ovarian stimulation protocols.

Understanding why LOD was criticized in the past is important.

Earlier LOD procedures were performed using monopolar electrodes, a technology that delivered uncontrolled electrical energy deep into the ovarian tissue. This sometimes caused deep burns, scar tissue formation (adhesions), and, in certain cases, significant and irreversible damage to the ovarian reserve.

The criticism of LOD was justified in the context of these older techniques. However, this is no longer how the procedure is performed at specialized centres.

The contemporary standard for LOD at specialised referral centres involves the use of micro bipolar electrodes, a significantly more precise and tissue-respecting technology. This approach is fundamentally different from the older monopolar technique in several important ways.

Micro bipolar electrodes require a high degree of surgical precision and skill. The energy is delivered in a controlled, targeted manner that avoids burns to the ovarian cortex, the outer layer of the ovary that contains the egg-producing follicles.

Because the cortex is preserved, the risk of adhesion formation is substantially reduced, and the risk of damage to the ovarian reserve is minimised.

An additional distinction of the modern approach is that the number of drilling points is not standardised or fixed. There is no universal protocol that specifies a set number of holes for every patient.

Instead, the number of drilling points typically ranges from 4 to 10 and is determined individually based on the ovarian appearance on ultrasound and direct laparoscopic findings at the time of surgery.

No two ovaries are treated identically. This level of personalisation is what distinguishes expert PMOS surgery from a generic procedural approach.

For women who are appropriate candidates, micro bipolar LOD offers several practical advantages that are particularly relevant for patients travelling from outside Mumbai for treatment.

The procedure is minimally invasive and is performed laparoscopically.

Most patients are discharged within 8 hours of the procedure. The recovery period is short enough that patients are typically able to return to their home city the following day. From a fertility standpoint, most women are able to attempt natural conception within the following menstrual cycle.

From a fertility perspective, one of the most important benefits of successful micro-bipolar LOD is the possibility of avoiding IVF altogether. This can significantly reduce the emotional stress, physical burden, and financial costs often associated with repeated IVF cycles.

In specialist PMOS practice, it is not uncommon to see women being advised to proceed directly to IVF without first undergoing properly optimised ovulation induction protocols or appropriate surgical evaluation.

However, many of these women, when assessed carefully and treated with micro-bipolar LOD where clinically indicated, can resume ovulation and conceive naturally.

At Shree IVF Clinic, Dr. Jay Mehta leads one of India’s national referral centres for resistant PMOS and complex ovulation disorders.

Women travel from across the country specifically for microbipolar LOD, reflecting the specialised nature of this technique and the limited number of centres offering it at this standard.

If you have been advised to proceed directly to IVF without a clear explanation of why non-surgical and surgical alternatives are not appropriate for your case, seeking a second specialist opinion before committing to IVF is a reasonable and well-informed decision.

To learn more about personalized treatment protocols or to schedule a clinical evaluation, international and domestic patients can contact the PMOS Clinic in Mumbai, India, directly via their dedicated helpline at 1800-268-4000.

• Ovulation Induction: Letrozole is the preferred first-line oral drug due to its superior efficacy. If oral agents fail, closely monitored injectable gonadotropins (hMG or recombinant FSH) are introduced to safely stimulate follicle growth.

• Metformin Therapy: Used alongside ovulation drugs to counter insulin resistance. Metformin optimizes the ovary’s metabolic environment, lowering male hormones and enhancing medication response.

• Lifestyle Interventions: For overweight patients, a 10% reduction in total body weight through targeted diet and exercise can independently restore natural ovulation by treating the metabolic root cause.

• Considered IVF: While In Vitro Fertilization remains an excellent tool for resistant cases, it should serve as a considered milestone rather than a default initial recommendation.

When to Seek a Second Opinion

Consider consulting a specialist in resistant PMOS if you face any of these clinical red flags:

• You are advised to do IVF without a clear explanation of why optimized ovulation induction failed.

• Ovarian surgery is recommended before your stimulation protocols have been fully maximized.

• A previous Laparoscopic Ovarian Drilling (LOD) failed, and you need to verify if it was performed correctly.

• Your protocol feels generic rather than meticulously tailored to your unique hormone levels and ultrasound scans.

Evaluating your reproductive health means checking all connected biological highways. Just as safeguarding the importance of the fallopian tubes in fertility ensures a clear physical path, managing PMOS ensures a receptive metabolic environment.

Learn how these factors interact in our guide on PMOS Causes and Hormonal Mechanisms.

If you feel your current treatment plan isn’t fully optimized or personalized to your metabolic profile, you don’t have to guess your next steps. Consult with our specialized reproductive endocrinology team for a comprehensive second opinion.